These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8402511)

  • 1. A large private university hospital system. The Johns Hopkins Oncology Center.
    Lenhard RE
    Cancer; 1993 Nov; 72(9 Suppl):2820-3. PubMed ID: 8402511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of clinical trial protocols on patient care in a community hospital.
    McKenna RJ
    Cancer; 1993 Nov; 72(9 Suppl):2828-33. PubMed ID: 8402513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families?
    Grossman SA; Piantadosi S; Covahey C
    J Clin Oncol; 1994 Oct; 12(10):2211-5. PubMed ID: 7931491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy and treatment scheduling: the Johns Hopkins Oncology Center Outpatient Department.
    Majidi F; Enterline JP; Ashley B; Fowler ME; Ogorzalek LL; Gaudette R; Stuart GJ; Fulton M; Ettinger DS
    Proc Annu Symp Comput Appl Med Care; 1993; ():154-8. PubMed ID: 8130453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of clinical trial protocols on patient care systems at the University of Texas M.D. Anderson Cancer Center.
    Huber SL
    Cancer; 1993 Nov; 72(9 Suppl):2824-7. PubMed ID: 8402512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on: "Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial." Kwon ED, Drake CG, Scher HI, Fizazi K, Bossi A, van den Eertwegh AJ, Krainer M, Houede N, Santos R, Mahammedi H, Ng S, Maio M, Franke FA, Sundar S, Agarwal N, Bergman AM, Ciuleanu TE, Korbenfeld E, Sengeløv L, Hansen S, Logothetis C, Beer TM, McHenry MB, Gagnier P, Liu D, Gerritsen WR, CA184-043 Investigators. Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA, Electronic address: kwon.eugene@mayo.edu; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA; Institut Gustave Roussy, University of Paris-Sud, Villejuif, France; Institut Gustave Roussy, Villejuif, France; VU University Medical Centre, Amsterdam, Netherlands; Vienna General Hospital, Medical University Vienna, Vienna, Austria; Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France; Centro Médico Austral, Buenos Aires, Argentina; Centre Jean Perrin, Clermont-Ferrand, France; St John of God Hospital, Subiaco, WA, Australia; University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy; Hospital de Caridade de Ijuí, Ijuí, Brazil; Nottingham University Hospital, Nottingham, UK; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania; Hospital Británico de Buenos Aires, Buenos Aires, Argentina; Herlev Hospital, Herlev, Denmark; Odense University Hospital, Odense, Denmark; University of Texas MD Anderson Cancer Center, Houston,
    Trump D
    Urol Oncol; 2016 May; 34(5):249-50. PubMed ID: 25907621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International transfer of the Johns Hopkins Oncology Center clinical information system.
    Hannan T
    MD Comput; 1994; 11(2):92-9. PubMed ID: 8201892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Johns Hopkins is investigating study in India by a professor.
    N Y Times Web; 2001 Jul; ():A15. PubMed ID: 12154825
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary brain tumors, delta 24 and tumor metabolism. Interview by Rona Williamson.
    Gilbert MR
    Expert Rev Neurother; 2013 Apr; 13(4):353-5. PubMed ID: 23545051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AUTRES--the Johns Hopkins Hospital automated resume.
    Lenhard RE; Buchman JP; Achuff SC; Kahane SN; Macmanus CJ
    J Med Syst; 1991 Jun; 15(3):237-47. PubMed ID: 1804925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
    Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
    J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growing public scrutiny of FDA clinical trials: ethical and regulatory compliance to avoid "uninformed consent" and financial conflicts of interest.
    Ronai SE
    Conn Med; 2001 Nov; 65(11):661-6. PubMed ID: 11766553
    [No Abstract]   [Full Text] [Related]  

  • 14. The Johns Hopkins Urban Health Institute: A collaborative response to urban health issues.
    Fox CE; Morford TG; Fine A; Gibbons MC
    Acad Med; 2004 Dec; 79(12):1169-74. PubMed ID: 15563651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Out-patient treatment for cancer patients at cancer chemotherapy centers in university hospitals].
    Uramoto H; Iwashige A; Kagami S; Narimatsu M; Yamazaki K; Kabashima M; Kadota T; Shinohara Y; Ichiki T; Iwamoto M; Tsukada J
    J UOEH; 2005 Dec; 27(4):359-65. PubMed ID: 16358929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.
    Daugherty CK
    J Clin Oncol; 1999 May; 17(5):1601-17. PubMed ID: 10334550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managed care at the Johns Hopkins Hospital.
    Nurs Adm Q; 1993; 17(3):54-79. PubMed ID: 8502423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.